TAXIS Pharmaceuticals Chief Scientific Officer Ajit Parhi, PhD, discusses dihydrofolate reductase inhibitors as a novel approach to combat resistant Neisseria gonorrhoeae.
Ajit Parhi, PhD
Advertisement
Parhi is the Chief Scientific Officer of TAXIS Pharmaceuticals.
Articles by Ajit Parhi, PhD
Advertisement
Latest Updated Articles
A Group of Antimicrobial Compounds Shows Novelty Action Against Multidrug-Resistant GonorrheaPublished: July 14th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Patient With Novel Strain of Avian Influenza Dies
2
Ethiopia Investigates Marburg Virus Disease Outbreak
3
Cefiderocol Shows Activity Against Difficult-to-Treat Pathogens
4
New Combination Antibiotic Emerges to Tackle Escalating Gram-Negative Resistance Threat
5
